Cart
sales@molnova.com
RO-0335
CAS No. 867365-76-2
RO-0335( —— )
Catalog No. M24875 CAS No. 867365-76-2
RO-0335 is a potent diphenylether nonnucleoside reverse transcriptase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 110 | In Stock |
|
| 10MG | 178 | In Stock |
|
| 25MG | 410 | In Stock |
|
| 50MG | 605 | In Stock |
|
| 100MG | 860 | In Stock |
|
| 500MG | 1728 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRO-0335
-
NoteResearch use only, not for human use.
-
Brief DescriptionRO-0335 is a potent diphenylether nonnucleoside reverse transcriptase inhibitor.
-
DescriptionRO-0335 is a potent diphenylether nonnucleoside reverse transcriptase inhibitor. RO-0335 inhibits Wt HIV-1 (IC50 = 1.1 nM) and retained activity (IC50< 100 nM) against 92% of a large number of NNRTI-resistant clinical isolates.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetReverse Transcriptase
-
RecptorReverse Transcriptase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number867365-76-2
-
Formula Weight573.22
-
Molecular FormulaC21H13BrCl2FN3O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:200mg/ml(348.91mM; need ultrasonic)
-
SMILESNS(c(cc1)cc(Cl)c1NC(Cc(ccc(Br)c1Oc2cc(Cl)cc(C#N)c2)c1F)=O)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Javanbakht H , Ptak R G , Chow E , et al. In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor[J]. Antiviral Research, 2010, 86(2):212-219.
molnova catalog
related products
-
Stavudine
Stavudine is a nucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
-
GS-7340 Tenofovir al...
Tenofovir Alafenamide (GS-7340) is a prodrug of tenofovir, which is a reverse transcriptase inhibitor, used to treat HIV and Hepatitis B.
-
IQP-0528
IQP-0528 is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI) that has potential for the treatment of HIV infection by blocking viral entry and shows antiviral activity as a microbicidal gel.
